von Willebrand factor: ristocetin cofactor complex activity (vWF:RCO) IVD, reagent

This category includes reagents designed to work with in vitro diagnostic (IVD) systems for measuring von Willebrand factor:ristocetin cofactor activity (vWF:RCO) in patient samples. These reagents help diagnose and monitor bleeding disorders, particularly von Willebrand disease, by quantifying the clotting protein’s function in plasma or whole blood. Clinicians rely on these tests to assess coagulation risks and guide treatment decisions for patients with suspected or confirmed deficiencies.

Reagents in this category are typically classified as in vitro diagnostics and may require regulatory compliance such as CE marking (EU) or FDA clearance (US) depending on their intended use. They are often supplied as lyophilized powders, liquid solutions, or kits requiring reconstitution before use. Availability varies by region, with some reagents distributed globally while others are limited to specific markets based on local regulatory pathways.